Evaluation of Intratracheal Salbutamol Effects in Addition to Surfactant in the Clinical Course of Premature Neonates with Respiratory Distress Syndrome

Overview

Journal J Res Med Sci

Specialty General Medicine

Date 2023 Jul 27

PMID 37496643

Authors

Razieh Moazami Goudarzi

Zohreh Badiee

Alireza Sadeghnia

Behzad Barekatain

Affiliations

Soon will be listed here.

Abstract

Background: In addition to surfactant deficiency, secretion of fluid from blood to the lungs and increase in the fluid content of the lung play significant roles in the pathogenesis of respiratory distress syndrome (RDS). Thus, we aimed to evaluate the effect of salbutamol (a beta-agonist) on fluid clearance from the lungs in neonates with RDS.

Materials And Methods: This randomized controlled clinical trial included 82 neonates with RDS admitted to the neonatal intensive care units of Alzahra and Shahid Beheshti Hospitals of Isfahan University of Medical Science from 2017 to 2018. Patients were recruited through convenience sampling. They were randomized into two groups, using simple randomization: 42 were only treated with intra-tracheal surfactant (control group) and 40 with intra-tracheal surfactant plus salbutamol (intervention group). The two groups were compared regarding intubation surfactant administration and extubation (INSURE) failure, duration of nasal continuous positive airway pressure, intubation, oxygen therapy, morbidity, and mortality.

Results: INSURE failure leading to mechanical ventilation occurred in 3 neonates in the control group and 2 in the intervention group ( = 0.680). Mean hospital length of stay did not differ significantly between groups ( = 0.230). Comparison of controls with the intervention group regarding complications and the incidence of morbidities revealed no statistically significant difference ( > 0.05).

Conclusion: Findings of this study were not in favor of the routine use of salbutamol in neonates with RDS as it did not improve the course of the disease among newborns.

References

Nimmo A, Carstairs J, Patole S, Whitehall J, Davidson K, Vink R . Intratracheal administration of glucocorticoids using surfactant as a vehicle. Clin Exp Pharmacol Physiol. 2002; 29(8):661-5. DOI: 10.1046/j.1440-1681.2002.03712.x. View

Najafian B, Fakhraie S, Afjeh S, Kazemian M, Shohrati M, Saburi A . Early surfactant therapy with nasal continuous positive airway pressure or continued mechanical ventilation in very low birth weight neonates with respiratory distress syndrome. Iran Red Crescent Med J. 2014; 16(4):e12206. PMC: 4028758. DOI: 10.5812/ircmj.12206. View

Armangil D, Yurdakok M, Korkmaz A, Yigit S, Tekinalp G . Inhaled beta-2 agonist salbutamol for the treatment of transient tachypnea of the newborn. J Pediatr. 2011; 159(3):398-403.e1. DOI: 10.1016/j.jpeds.2011.02.028. View

Dehdashtian M, Malakian A, Aramesh M, Mazori A, Aletayeb M, Shirani A . Effectiveness of intratracheal salbutamol in addition to surfactant on the clinical course of newborns with respiratory distress syndrome: a clinical trial. Ital J Pediatr. 2016; 42:6. PMC: 4717645. DOI: 10.1186/s13052-016-0215-1. View

Yeh T, Chen C, Wu S, Husan Z, Li T, Hsieh W . Intratracheal Administration of Budesonide/Surfactant to Prevent Bronchopulmonary Dysplasia. Am J Respir Crit Care Med. 2015; 193(1):86-95. DOI: 10.1164/rccm.201505-0861OC. View

Yeh T, Lin H, Chang C, Wu T, Su B, Li T . Early intratracheal instillation of budesonide using surfactant as a vehicle to prevent chronic lung disease in preterm infants: a pilot study. Pediatrics. 2008; 121(5):e1310-8. DOI: 10.1542/peds.2007-1973. View

Malakian A, Dehdashtian M, Aramesh M, Aletayeb M, Heidari S . The effect of inhaled salbutamol on the outcomes of transient tachypnea of the newborn. J Chin Med Assoc. 2018; 81(11):990-997. DOI: 10.1016/j.jcma.2018.01.015. View

Rotschild A, Solimano A, Puterman M, Smyth J, Sharma A, Albersheim S . Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia. J Pediatr. 1989; 115(6):984-91. DOI: 10.1016/s0022-3476(89)80755-3. View

Baines D, Folkesson H, Norlin A, Bingle C, Yuan H, Olver R . The influence of mode of delivery, hormonal status and postnatal O2 environment on epithelial sodium channel (ENaC) expression in perinatal guinea-pig lung. J Physiol. 2000; 522 Pt 1:147-57. PMC: 2269744. DOI: 10.1111/j.1469-7793.2000.t01-2-00147.xm. View

10.

Rieger-Fackeldey E, Reinhardt D, Schulze A . Effects of inhaled formoterol compared with salbutamol in ventilated preterm infants. Pulm Pharmacol Ther. 2004; 17(5):293-300. DOI: 10.1016/j.pupt.2004.06.003. View

11.

OKane C, McKeown S, Perkins G, Bassford C, Gao F, Thickett D . Salbutamol up-regulates matrix metalloproteinase-9 in the alveolar space in the acute respiratory distress syndrome. Crit Care Med. 2009; 37(7):2242-9. DOI: 10.1097/CCM.0b013e3181a5506c. View

12.

Flemmer A, Simbruner G, Muenzer S, Proquitte H, Haberl C, Nicolai T . Effect of lung water content, manipulated by intratracheal furosemide, surfactant, or a mixture of both, on compliance and viscoelastic tissue forces in lung-lavaged newborn piglets. Crit Care Med. 2000; 28(6):1911-7. DOI: 10.1097/00003246-200006000-00038. View

13.

Perkins G, Nathani N, McAuley D, Gao F, Thickett D . In vitro and in vivo effects of salbutamol on neutrophil function in acute lung injury. Thorax. 2006; 62(1):36-42. PMC: 2111273. DOI: 10.1136/thx.2006.059410. View

14.

Frank J, Wang Y, OSORIO O, Matthay M . Beta-adrenergic agonist therapy accelerates the resolution of hydrostatic pulmonary edema in sheep and rats. J Appl Physiol (1985). 2000; 89(4):1255-65. DOI: 10.1152/jappl.2000.89.4.1255. View

15.

Ekhaguere O, Okonkwo I, Batra M, Hedstrom A . Respiratory distress syndrome management in resource limited settings-Current evidence and opportunities in 2022. Front Pediatr. 2022; 10:961509. PMC: 9372546. DOI: 10.3389/fped.2022.961509. View

16.

Chen X, Eaton D, Jain L . Beta-adrenergic regulation of amiloride-sensitive lung sodium channels. Am J Physiol Lung Cell Mol Physiol. 2002; 282(4):L609-20. DOI: 10.1152/ajplung.00356.2001. View

17.

Lee H, Arnon S, Silverman M . Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome. Arch Dis Child Fetal Neonatal Ed. 1994; 70(3):F218-22. PMC: 1061045. DOI: 10.1136/fn.70.3.f218. View

18.

Mwansa-Kambafwile J, Cousens S, Hansen T, Lawn J . Antenatal steroids in preterm labour for the prevention of neonatal deaths due to complications of preterm birth. Int J Epidemiol. 2010; 39 Suppl 1:i122-33. PMC: 2845868. DOI: 10.1093/ije/dyq029. View

19.

Sweet D, Carnielli V, Greisen G, Hallman M, Ozek E, Te Pas A . European Consensus Guidelines on the Management of Respiratory Distress Syndrome - 2019 Update. Neonatology. 2019; 115(4):432-450. PMC: 6604659. DOI: 10.1159/000499361. View

20.

Sakuma T, Gu X, Wang Z, Maeda S, Sugita M, Sagawa M . Stimulation of alveolar epithelial fluid clearance in human lungs by exogenous epinephrine. Crit Care Med. 2006; 34(3):676-81. PMC: 2765117. DOI: 10.1097/01.CCM.0000201403.70636.0F. View